An original approach was used to better evaluate the capacity of a prognostic marker using published survival curves

J Clin Epidemiol. 2014 Apr;67(4):441-8. doi: 10.1016/j.jclinepi.2013.10.022.

Abstract

Objectives: Predicting chronic disease evolution from a prognostic marker is a key field of research in clinical epidemiology. However, the prognostic capacity of a marker is not systematically evaluated using the appropriate methodology. We proposed the use of simple equations to calculate time-dependent sensitivity and specificity based on published survival curves and other time-dependent indicators as predictive values, likelihood ratios, and posttest probability ratios to reappraise prognostic marker accuracy.

Study design and setting: The methodology is illustrated by back calculating time-dependent indicators from published articles presenting a marker as highly correlated with the time to event, concluding on the high prognostic capacity of the marker, and presenting the Kaplan-Meier survival curves. The tools necessary to run these direct and simple computations are available online at http://www.divat.fr/en/online-calculators/evalbiom.

Results: Our examples illustrate that published conclusions about prognostic marker accuracy may be overoptimistic, thus giving potential for major mistakes in therapeutic decisions.

Conclusion: Our approach should help readers better evaluate clinical articles reporting on prognostic markers. Time-dependent sensitivity and specificity inform on the inherent prognostic capacity of a marker for a defined prognostic time. Time-dependent predictive values, likelihood ratios, and posttest probability ratios may additionally contribute to interpret the marker's prognostic capacity.

Keywords: Likelihood ratios; Predictive values; Prognostic factor; Sensitivity; Specificity; Survival analysis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers
  • Chronic Disease
  • Humans
  • Kaplan-Meier Estimate*
  • Likelihood Functions*
  • Predictive Value of Tests
  • Prognosis*
  • Sensitivity and Specificity

Substances

  • Biomarkers